Barclays’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-61,084
Closed -$346K 5628
2025
Q3
$346K Sell
61,084
-5,115
-8% -$26.2K ﹤0.01% 4005
2025
Q2
$252K Buy
66,199
+19,586
+42% +$60.8K ﹤0.01% 4136
2025
Q1
$123K Sell
46,613
-18,748
-29% -$61.1K ﹤0.01% 4319
2024
Q4
$231K Buy
65,361
+24,717
+61% +$94.7K ﹤0.01% 4236
2024
Q3
$185K Buy
40,644
+30,902
+317% +$149K ﹤0.01% 4343
2024
Q2
$42.4K Sell
9,742
-10,562
-52% -$46.4K ﹤0.01% 4266
2024
Q1
$102K Sell
20,304
-19,381
-49% -$109K ﹤0.01% 4428
2023
Q4
$249K Buy
39,685
+34,563
+675% +$198K ﹤0.01% 4323
2023
Q3
$36.5K Sell
5,122
-634
-11% -$5K ﹤0.01% 3993
2023
Q2
$58.7K Sell
5,756
-67,692
-92% -$706K ﹤0.01% 3769
2023
Q1
$666K Buy
+73,448
New +$538K ﹤0.01% 3054
2021
Q4
Sell
-814
Closed -$5K 4671
2021
Q3
$5K Buy
814
+44
+6% +$263 ﹤0.01% 4603
2021
Q2
$5K Sell
770
-5,079
-87% -$30.6K ﹤0.01% 4748
2021
Q1
$39K Buy
5,849
+3,591
+159% +$24.6K ﹤0.01% 4250
2020
Q4
$12K Sell
2,258
-865
-28% -$6.77K ﹤0.01% 4739
2020
Q3
$24K Buy
3,123
+138
+5% +$1.08K ﹤0.01% 4863
2020
Q2
$22K Buy
+2,985
New +$26.2K ﹤0.01% 5185
2019
Q4
Sell
-142
Closed -$1K 6766
2019
Q3
$1K Buy
142
+141
+14,100% +$795 ﹤0.01% 6610
2019
Q2
$0 Sell
1
-2,086
-100% -$6.82K ﹤0.01% 7241
2019
Q1
$6K Buy
2,087
+1,890
+959% +$6.49K ﹤0.01% 6680
2018
Q4
$1K Sell
197
-2,521
-93% -$11.8K ﹤0.01% 6833
2018
Q3
$16K Buy
2,718
+2,000
+279% +$10.2K ﹤0.01% 6529
2018
Q2
$3K Sell
718
-807
-53% -$8.29K ﹤0.01% 6792
2018
Q1
$19K Buy
+1,525
New +$20.5K ﹤0.01% 6452